Selvita Valuation

Is SLV undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SLV when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate SLV's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate SLV's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for SLV?

Key metric: As SLV is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for SLV. This is calculated by dividing SLV's market cap by their current earnings.
What is SLV's PE Ratio?
PE Ratio17.3x
Earningszł54.09m
Market Capzł934.29m

Price to Earnings Ratio vs Peers

How does SLV's PE Ratio compare to its peers?

The above table shows the PE ratio for SLV vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average62.3x
CLN Celon Pharma
73.8x-33.9%zł1.4b
SVE Synthaverse
67.6xn/azł300.8m
TARSONS Tarsons Products
63.2x27.7%₹21.8b
524394 Vimta Labs
44.6xn/a₹22.0b
SLV Selvita
17.3x21.1%zł934.3m

Price-To-Earnings vs Peers: SLV is good value based on its Price-To-Earnings Ratio (17.3x) compared to the peer average (62.3x).


Price to Earnings Ratio vs Industry

How does SLV's PE Ratio compare vs other companies in the European Life Sciences Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
SLV 17.3xIndustry Avg. 38.2xNo. of Companies3PE020406080100+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: SLV is good value based on its Price-To-Earnings Ratio (17.3x) compared to the European Life Sciences industry average (38.6x).


Price to Earnings Ratio vs Fair Ratio

What is SLV's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SLV PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio17.3x
Fair PE Ratio67.7x

Price-To-Earnings vs Fair Ratio: SLV is good value based on its Price-To-Earnings Ratio (17.3x) compared to the estimated Fair Price-To-Earnings Ratio (67.7x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SLV forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentzł50.90
zł62.15
+22.1%
16.0%zł78.70zł47.00n/a6
Dec ’25zł51.00
zł66.40
+30.2%
11.7%zł78.70zł58.00n/a6
Nov ’25zł53.70
zł69.23
+28.9%
11.1%zł78.70zł58.00n/a6
Oct ’25zł57.50
zł69.65
+21.1%
10.4%zł78.70zł58.00n/a6
Sep ’25zł67.00
zł70.98
+5.9%
7.7%zł78.70zł62.70n/a6
Aug ’25zł68.90
zł70.98
+3.0%
7.7%zł78.70zł62.70n/a6
Jul ’25zł67.70
zł70.98
+4.8%
7.7%zł78.70zł62.70n/a6
Jun ’25zł66.00
zł70.98
+7.6%
7.7%zł78.70zł62.70n/a6
May ’25zł69.60
zł68.98
-0.9%
8.5%zł78.70zł62.70n/a5
Apr ’25zł66.70
zł71.58
+7.3%
7.3%zł78.70zł65.00n/a5
Mar ’25zł59.00
zł70.18
+18.9%
10.5%zł78.70zł58.00n/a5
Feb ’25zł59.20
zł70.18
+18.5%
10.5%zł78.70zł58.00n/a5
Jan ’25zł58.50
zł77.94
+33.2%
26.5%zł117.50zł58.00n/a5
Dec ’24zł63.00
zł77.94
+23.7%
26.5%zł117.50zł58.00zł51.005
Nov ’24zł62.70
zł81.74
+30.4%
22.3%zł117.50zł66.00zł53.705
Oct ’24zł62.50
zł84.70
+35.5%
20.5%zł117.50zł66.00zł57.505
Sep ’24zł67.20
zł84.90
+26.3%
20.2%zł117.50zł67.00zł67.005
Aug ’24zł74.40
zł84.90
+14.1%
20.2%zł117.50zł67.00zł68.905
Jul ’24zł67.90
zł84.90
+25.0%
20.2%zł117.50zł67.00zł67.705
Jun ’24zł68.50
zł86.10
+25.7%
18.6%zł117.50zł73.00zł66.005
May ’24zł75.00
zł86.10
+14.8%
18.6%zł117.50zł73.00zł69.605
Apr ’24zł75.00
zł93.94
+25.3%
17.7%zł117.50zł73.00zł66.705
Mar ’24zł80.90
zł96.34
+19.1%
14.7%zł117.50zł77.00zł59.005
Feb ’24zł84.90
zł90.84
+7.0%
10.3%zł102.20zł77.00zł59.205
Jan ’24zł82.90
zł90.84
+9.6%
10.3%zł102.20zł77.00zł58.505
Dec ’23zł80.80
zł90.84
+12.4%
10.3%zł102.20zł77.00zł63.005

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 01:12
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Selvita S.A. is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kamil KliszczBiuro maklerskie mBanku
Beata Szparaga-WasniewskaBiuro maklerskie mBanku
Sylwia JaskiewiczDom Maklerski Banku Ochrony Srodowiska S.A.